Use of Human Milk Cream to Decrease Length of Stay in Extremely Premature Infants
Studying Bronchopulmonary dysplasia
Last synced from ClinicalTrials.gov
Key facts
- Sponsor
- Baylor College of Medicine
- Principal Investigator
- Amy B Hair, MDTexas Children's Hospital, Baylor College of Medicine
- Intervention
- Cream Supplement group(dietary_supplement)
- Enrollment
- 210 enrolled
- Eligibility
- All sexes
- Timeline
- 2015 – 2025
Study locations (8)
- Orlando Health, Inc. - Winnie Palmer Hospital for Women and Babies, Orlando, Florida, United States
- Michigan State University, East Lansing, Michigan, United States
- Children's Hospital Medical Center of Akron, Boardman, Ohio, United States
- Cook Children's Medical Center, Fort Worth, Texas, United States
- Baylor College of Medicine / Texas Children's Hospital, Houston, Texas, United States
- University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States
- Wasatch Neonatal, Orem, Utah, United States
- University Hospital, Innsbruck, Austria
Collaborators
Prolacta Bioscience · Medical University Innsbruck · The University of Texas Health Science Center, Houston · Michigan State University · Akron Children's Hospital · Timpanogos Regional Hospital · Orlando Health, Inc. · St. Louis Children's Hospital · Baylor Scott and White Health · Westchester Medical Center · Unity Health Toronto · St. John Hospital & Medical Center · Texas Tech University Health Sciences Center, El Paso · Cook Children's Medical Center · University of Oklahoma
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02475434 on ClinicalTrials.govOther trials for Bronchopulmonary dysplasia
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06373289Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm InfantsUniversity of Alabama at Birmingham
- RECRUITINGPHASE2NCT07561125Effects of IVIG for BPD in Preterm Infant Born at 28 Weeks and BelowInternational Peace Maternity and Child Health Hospital
- RECRUITINGNCT07109791National Surveillance and Prevention of Neonatal VAPUniversity of Alberta
- RECRUITINGPHASE2NCT06915441Lipid Infusions to Optimize Nutrition TrialThe University of Texas Health Science Center, Houston
- RECRUITINGPHASE1, PHASE2NCT07101640PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary DysplasiaDuke University
- RECRUITINGNCT07273643Characterization of Extracellular Vesicles From the Cord Blood of Extremely Preterm New Borns and Their Correlation With Severe Morbidity and MortalityUniversity Hospital, Montpellier
- RECRUITINGEARLY PHASE1NCT07120971Metformin for Premature Infants With Bronchopulmonary DysplasiaMedical College of Wisconsin
- RECRUITINGNCT07134387Long-Term Burden of BPD and Health-Related Quality of Life (BronQ Family)Global Foundation for the Care of Newborn Infants